Annual report 2016 now online In our annual report, we look back at compelling RIVM projects and research in which RIVM was involved in 2016. Our expertise is broader than what we can showcase in this report.
Risks of potential release of genetically modified mosquitoes evaluated On Saba, a Dutch Caribbean island, diseases such as dengue, chikungunya and zika can be reduced by the use of genetically modified mosquitoes.
Resistant bacteria in wastewater Our wastewater contains bacteria that are resistant to antibiotics. Residues of antibiotics are also found in wastewater.
Trend scenario PHF- 2018 identifies societal challenges for the future If historical trends continue unchanged, dementia will be the leading cause of disease burden in 2040 and the main cause of death.
Antimicrobial resistance is stable, but alertness remains necessary The number of bacteria strains resistant to antibiotics in humans has remained stable in the Netherlands over the past year.
Lyme disease costs EUR 20 million annually The societal costs of Lyme disease have been determined for the Netherlands for the first time. The disease appears to cost nearly EUR 20 million each year.
Slight increase of ammonia emissions In 2015 slightly more ammonia was emitted in the Netherlands than in 2014 and the ceiling set by the European Union was met (128 kilotons).
TIME honours Guus Velders of RIVM TIME has named Professor Guus Velders of RIVM as one of the 100 most influential people in the world.
Every year, 300,000 tick bites in urban areas One in 5 tick bites occurs in an urban area. Although most tick bites occur in the countryside, many people are bitten in urban areas as well.
It is time to change: adapting behaviours for a sustainable and healthy Europe The state of the environment, our health, and levels of social equity are closely interrelated.